The share of TherapeuticsMD Inc. underperforms on Thursday compared to competitors

Shares of TherapeuticsMD Inc. TXMD,
-5.41%
5.41% to $ 1.75 Thursday, on what turned out to be an all round bad trading session for the stock market, with the NASDAQ Composite Index COMP,
-0.72%
down 0.72% to 13,865.36 and Dow Jones Industrial Average DJIA,
-0.38%
decreased by 0.38% to 31,493.34. This was the stock’s sixth consecutive day of losses. TherapeuticsMD Inc. closed $ 1.00 lower from its 52-week high of $ 2.75, which the company hit on Feb. 9.

The stock underperformed Thursday compared to some of its competitors, such as Apple Inc. AAPL,
-0.86%
fell 0.86% to $ 129.71, Alphabet Inc. Cl A GOOGL,
-0.60%
declined 0.60% to $ 2,105.81, and Facebook Inc. Cl A FB,
-1.53%
decreased 1.53% to $ 269.39. The trade volume (18.3 million) eclipsed the 50-day average volume of 12.4 million.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.

Source